Anoctamin-1 (ANO1 or TMEM16A) (N-Terminus) Antibody - Western Blot Validated

Biological Background

This antibody is suited for researchers who want to analyze Anoctamin-1 N-Terminus (ANO1) and relate it to cell-state biology. Anoctamin-1 N-Terminus is a membrane-embedded regulator of ionic or osmotic balance in cells. Its behavior can reflect changes in differentiation state, stress, or remodeling of cellular architecture.

In some datasets and protocols, it is referenced by the gene symbol ANO1.

Use in the Laboratory

Modulators that affect trafficking, phosphorylation, or ligand binding can change apparent distribution and signal intensity. Because regulation can be multi-layered, combining abundance and localization information can sharpen conclusions.

Interpreting changes can benefit from separating expression differences from redistribution, particularly when the target cycles between compartments.

To keep datasets interpretable, labs often document:

• relative abundance across engineered constructs
• stimulus-dependent trafficking and turnover
• patterns consistent with apical or basolateral sorting

Version Notes

When samples are prepared in reducing conditions, some epitopes become more accessible; this version is designed with that context in mind. If your study compares multiple conditions, keep acquisition and processing settings stable to avoid confounding. Small differences in preparation can reshape apparent localization, so interpret results in context.

When interpreting Anoctamin-1 N-Terminus, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

Use the denaturing-format variant when your project demands Anoctamin-1 N-Terminus (ANO1) readouts that respect preparation constraints.